National Drug Control Policy
- All
- News
- Videos
-
"Only Way To Solve World's Problems": White House Official On "Closer" US-India Ties
Dr Rahul Gupta, Director of the Office of National Drug Control Policy, said it is important for the safety security and health of the world that the two nations accelerate their partnership.
-
Indian-American Confirmed As Director Of US National Drug Control Policy
Dr Rahul Gupta, a veteran Indian-American primary care physician, has been confirmed by US Senate as the Director of National Drug Control Policy, making him the first medical doctor to ever lead the White House Office of National Drug Control Policy
-
WADA Formally Responds To US Report Demanding Reform
In a letter to James W. Carroll, director of the office of National Drug Control Policy (ONDCP), WADA president Witold Banka reiterated the agency's "disappointment" at what WADA says are factual inaccuracies in the report.
-
Donald Trump To Nominate White House Aide For Drug Czar: White House
US President Donald Trump intends to nominate White House aide Jim Carroll to serve as director of the Office of National Drug Control Policy, a post popularly known as the drug czar, the White House said in a statement on Friday.
-
Centre Not Considering Change In Essential Drugs' Pricing Policy
Government is also working to bring a new method to decide prices of 'new drugs' to avoid delays in launching them in the market.
-
Government Forms Committee to Review Drug Pricing Policy
As stipulated under DPCO 2013, drug price regulator NPPA fixes the ceiling price of essential medicines of schedule-I.
-
Government to Slash Prices of Over 100 Drugs; Pharma Firms Call it 'Flawed'
With spiralling costs of medicines becoming a major concern for the common man, the government now plans to bring down the prices of 108 drugs.
-
Price implementation under DPCO 2013 to impact profits: Wyeth
Government of India on May 15, 2013 notified the Drugs (Prices Control) Order, 2013 bringing into effect a new drug pricing policy applicable to 348 formulations listed in the National List of Essential Medicines (NLEM), Wyeth said in a filing to BSE.
-
New drug pricing policy may hit revenues up to 5 per cent: Dr Reddy's
The new drug pricing policy being implemented by the government may impact Dr Reddy's Laboratories revenues by 3-5 per cent from India, the drug maker said.
-
Government notifies new drug pricing policy
The government today said the new drug policy which aims at bringing more medicines under price control has been notified.
-
Pharma policy gets Cabinet nod, essential medicines to cost less
The government today cleared the National Pharmaceutical Pricing Policy that will bring 348 essential drugs under price control, leading to reduction in prices.
-
"Only Way To Solve World's Problems": White House Official On "Closer" US-India Ties
Dr Rahul Gupta, Director of the Office of National Drug Control Policy, said it is important for the safety security and health of the world that the two nations accelerate their partnership.
-
Indian-American Confirmed As Director Of US National Drug Control Policy
Dr Rahul Gupta, a veteran Indian-American primary care physician, has been confirmed by US Senate as the Director of National Drug Control Policy, making him the first medical doctor to ever lead the White House Office of National Drug Control Policy
-
WADA Formally Responds To US Report Demanding Reform
In a letter to James W. Carroll, director of the office of National Drug Control Policy (ONDCP), WADA president Witold Banka reiterated the agency's "disappointment" at what WADA says are factual inaccuracies in the report.
-
Donald Trump To Nominate White House Aide For Drug Czar: White House
US President Donald Trump intends to nominate White House aide Jim Carroll to serve as director of the Office of National Drug Control Policy, a post popularly known as the drug czar, the White House said in a statement on Friday.
-
Centre Not Considering Change In Essential Drugs' Pricing Policy
Government is also working to bring a new method to decide prices of 'new drugs' to avoid delays in launching them in the market.
-
Government Forms Committee to Review Drug Pricing Policy
As stipulated under DPCO 2013, drug price regulator NPPA fixes the ceiling price of essential medicines of schedule-I.
-
Government to Slash Prices of Over 100 Drugs; Pharma Firms Call it 'Flawed'
With spiralling costs of medicines becoming a major concern for the common man, the government now plans to bring down the prices of 108 drugs.
-
Price implementation under DPCO 2013 to impact profits: Wyeth
Government of India on May 15, 2013 notified the Drugs (Prices Control) Order, 2013 bringing into effect a new drug pricing policy applicable to 348 formulations listed in the National List of Essential Medicines (NLEM), Wyeth said in a filing to BSE.
-
New drug pricing policy may hit revenues up to 5 per cent: Dr Reddy's
The new drug pricing policy being implemented by the government may impact Dr Reddy's Laboratories revenues by 3-5 per cent from India, the drug maker said.
-
Government notifies new drug pricing policy
The government today said the new drug policy which aims at bringing more medicines under price control has been notified.
-
Pharma policy gets Cabinet nod, essential medicines to cost less
The government today cleared the National Pharmaceutical Pricing Policy that will bring 348 essential drugs under price control, leading to reduction in prices.
